Follow the 幸康 share price and the full management transaction log of the company, a listed equity based in Taiwan. Shares are quoted on the TW market, under the oversight of TWSE / TPEx (MOPS). Market capitalisation: €3bn. The latest transaction was reported on 27 April 2026 (Gift). Among the most active insiders: 呂惠清. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 6,083 of 28,957 companies
66.2
score / 100
Value
63
Quality
69
FCF yld5.8%
Earn yld5.7%
EV/EBITDA11.2x
ROE11%
Gross mgn36%
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
幸康 is a company listed on the XTAI market, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance patient well-being.